Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Meidakang Huakang Pharmaceutical is a prominent Chinese pharmaceutical manufacturer based in Mianyang, Sichuan Province. The company operates as a core subsidiary of the Meidakang Pharmaceutical Group, focusing on the production of high-quality traditional Chinese medicines (TCM) and chemical generic drugs. Its extensive manufacturing capabilities include GMP-certified lines for tablets, capsules, and granules, serving a wide range of therapeutic needs. Meidakang Huakang is particularly recognized for its cardiovascular treatments and anti-infective medications, which are distributed throughout the domestic Chinese market. By integrating modern pharmaceutical technology with traditional herbal expertise, the company maintains a robust presence in the primary healthcare sector. Their commitment to quality control and standardized production has established them as a reliable provider of essential medicines in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 四川美大康华康药业.